Metis Global Partners LLC lifted its stake in Colgate-Palmolive Company (NYSE:CL – Free Report) by 2.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 32,788 shares of the company’s stock after buying an additional 829 shares during the quarter. Metis Global Partners LLC’s holdings in Colgate-Palmolive were worth $2,980,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the stock. Cidel Asset Management Inc. grew its position in Colgate-Palmolive by 13.6% in the 2nd quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock valued at $29,912,000 after acquiring an additional 39,413 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Colgate-Palmolive by 18.6% during the second quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock valued at $2,752,000 after purchasing an additional 4,738 shares during the period. Secured Retirement Advisors LLC grew its holdings in shares of Colgate-Palmolive by 564.3% in the first quarter. Secured Retirement Advisors LLC now owns 20,406 shares of the company’s stock worth $1,912,000 after purchasing an additional 17,334 shares during the last quarter. Arista Wealth Management LLC purchased a new position in Colgate-Palmolive in the 2nd quarter worth about $571,000. Finally, Mraz Amerine & Associates Inc. bought a new stake in Colgate-Palmolive during the 2nd quarter valued at about $300,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of brokerages have commented on CL. The Goldman Sachs Group dropped their target price on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, October 2nd. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a research note on Monday, November 3rd. Morgan Stanley decreased their target price on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. Bank of America dropped their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Finally, Raymond James Financial cut their price target on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Nine research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $89.87.
Colgate-Palmolive Stock Up 1.9%
Shares of NYSE CL opened at $78.76 on Monday. The stock has a market capitalization of $63.48 billion, a PE ratio of 22.12, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The stock’s fifty day simple moving average is $79.73 and its two-hundred day simple moving average is $85.64.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The company had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 earnings per share. As a group, analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s payout ratio is presently 58.26%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- The 3 Best Retail Stocks to Shop for in August
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- 3 Stocks to Consider Buying in October
- AI Demand Is Coming—Is Microchip Technology Ready?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
